Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia "XANAP"

Completed

Phase N/A Results N/A

7 locations do not appear on the map due to incomplete addresses.

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact clinical-trials-contact@bayerhealthcare.com

Other Locations

Name City State Country Status
Name Unavailable Many Locations Hong Kong Unknown_status_icon
Name Unavailable Many Locations India Unknown_status_icon
Name Unavailable Many Locations Indonesia Unknown_status_icon
Name Unavailable Many Locations Korea, Republic of Unknown_status_icon
Name Unavailable Many Locations Malaysia Unknown_status_icon
Name Unavailable Many Locations Philippines Unknown_status_icon
Name Unavailable Many Locations Singapore Unknown_status_icon
Name Unavailable Many Locations Taiwan Unknown_status_icon
Name Unavailable Many Locations Thailand Unknown_status_icon
Name Unavailable Many Locations Vietnam Unknown_status_icon
Name Unavailable Many Locations Pakistan Unknown_status_icon